Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL
Clinical trial NCT04554459 · TERMINATED
Trial details
- NCT number
- NCT04554459
- Sponsor
- Institute of Hematology and Blood Transfusion, Czech Republic
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2023-09-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.